Scarica l'app Stockscreener
0.5846
20.37%
-0.1456
Precedente Chiudi:
$0.7302
Aprire:
$0.6775
Volume 24 ore:
14.14M
Relative Volume:
0.50
Capitalizzazione di mercato:
$28.26M
Reddito:
-
Utile/perdita netta:
$-16.26M
Rapporto P/E:
-0.4948
EPS:
-1.1814
Flusso di cassa netto:
$-13.50M
1 W Prestazione:
+137.91%
1M Prestazione:
+107.66%
6M Prestazione:
+1.49%
1 anno Prestazione:
-82.47%
Intervallo 1D:
$0.5743
$0.7072
Intervallo di 1 settimana:
$0.24
$1.74
Portata 52W:
$0.1853
$3.40
Intensity Therapeutics Inc Stock (INTS) Company Profile
Nome
Intensity Therapeutics Inc
Settore
Industria
Telefono
203-221-7381
Indirizzo
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Confronta INTS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.576 | 35.82M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.88 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.71 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
Will Intensity Therapeutics Inc. rebound enough to break even2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Will Intensity Therapeutics Inc. stock reach all time highs in 2025July 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
How to track smart money flows in Intensity Therapeutics Inc.Weekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
How interest rate cuts could boost Intensity Therapeutics Inc. stockJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Does Intensity Therapeutics Inc. show high probability of rebound2025 Key Highlights & Precise Buy Zone Tips - newser.com
Ranking Intensity Therapeutics Inc. among high performing stocks via tools2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
How Intensity Therapeutics Inc. stock performs in stagflationJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
How Intensity Therapeutics Inc. stock trades before earnings2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset - MSN
Intensity Therapeutics Stock Price, Quotes and Forecasts - Benzinga
Intensity Therapeutics Enters Securities Purchase Agreement - TipRanks
INTS to raise $4.0M via 5,000,000-share registered direct sale - Stock Titan
Intensity Therapeutics prices $4 million registered direct offering By Investing.com - Investing.com South Africa
Intensity Therapeutics announces pricing of $4M registered direct offering of common stock - MSN
Intensity Therapeutics Prices $4 Million Direct Offering - MarketScreener
Intensity Therapeutics prices 5M shares at 80c in registered direct offering - TipRanks
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
Intensity Therapeutics, Inc. (INTS) stock tumbles 30% as $4M direct offering sparks investor concern - parameter.io
Unexpected Surge: Analyzing INTS Performance - timothysykes.com
Intensity Therapeutics prices $4 million registered direct offering - Investing.com
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Biotech Bombshell: Intensity Therapeutics (INTS) Surges Nearly 400% on Major Cancer Trial News - ts2.tech
Intensity Therapeutics stock tumbles after pricing $4 million offering By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock tumbles after pricing $4 million offering - Investing.com
Intensity Therapeutics stock up nearly 400% on solid tumour data - Yahoo Finance
Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PR Newswire
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Why Intensity Therapeutics Inc. stock is favored by top institutionsWeekly Market Report & AI Optimized Trade Strategies - newser.com
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics - Yahoo! Finance UK
Volume spikes in Intensity Therapeutics Inc. stock – what they meanMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis toolsEarnings Miss & Verified Trade Idea Suggestions - newser.com
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know - inkl
US Stock Market top gainers and losers on October 30: Intensity Therapeutics, Inc. sees nearly 400% jump, - The Economic Times
Positive Phase 1/2 clinical data for cancer candidate drug propels Intensity Therapeutics (INTS.US) stock up by 395%. - 富途牛牛
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Intensity Therapeutics Shares Soar on Promising Cancer Trial Results - El-Balad.com
Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):